乳腺癌复发风险可能会持续10至32年。 - Suppr

Suppr

超能文献

Breast cancer recurrence risk can remain for 10 to 32 years.

作者信息

Fillon Mike

出版信息

CA Cancer J Clin. 2022 May;72(3):197-199. doi: 10.3322/caac.21724. Epub 2022 Mar 14.

DOI:10.3322/caac.21724

PMID:35285943

Abstract

摘要

相似文献

Breast cancer recurrence risk can remain for 10 to 32 years.

CA Cancer J Clin. 2022 May;72(3):197-199. doi: 10.3322/caac.21724. Epub 2022 Mar 14.

Local recurrence risk after previous salvage mastectomy.

Eur J Surg Oncol. 2016 Jul;42(7):980-5. doi: 10.1016/j.ejso.2016.03.008. Epub 2016 Mar 26.

Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.

Breast Cancer Res Treat. 2015 Dec;154(3):609-16. doi: 10.1007/s10549-015-3647-1. Epub 2015 Nov 24.

Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.

Clin Breast Cancer. 2016 Aug;16(4):284-90. doi: 10.1016/j.clbc.2015.11.002. Epub 2015 Nov 17.

Impact of oncotype DX recurrence score in the management of breast cancer cases.

Clin Breast Cancer. 2014 Jun;14(3):182-90. doi: 10.1016/j.clbc.2013.12.002. Epub 2013 Dec 27.

Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.

JAMA Oncol. 2017 Feb 9;3(2):186-193. doi: 10.1001/jamaoncol.2016.3340. Epub 2016 Oct 6.

Early breast cancer: adjuvant chemotherapy or radiotherapy, or both?

Acta Oncol. 2006;45(5):514-6. doi: 10.1080/02841860600839241.

[Local recurrence in premenopausal women with breast cancer: risk factors and effect of therapy].

Strahlenther Onkol. 2001 Jan;177(1):52-3.

Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy.

Ann Surg Oncol. 2002 Apr;9(3):256-65. doi: 10.1007/BF02573063.

Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence.

Cancer J Sci Am. 1999 Mar-Apr;5(2):77-83.

引用本文的文献

ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging.

Eur Radiol. 2025 Aug 14. doi: 10.1007/s00330-025-11819-3.

circEFR3A promotes breast cancer progression by sponging miR-590-3p to upregulate androgen receptor expression.

Oncol Lett. 2025 Jul 17;30(3):446. doi: 10.3892/ol.2025.15192. eCollection 2025 Sep.

Identification and validation of DNA methylation-driven gene OSR1 as a novel tumor suppressor for the diagnosis and prognosis of breast cancer.

Front Genet. 2025 Jul 7;16:1583620. doi: 10.3389/fgene.2025.1583620. eCollection 2025.

Exploring the utility of ctDNA testing in high-risk breast cancer patients in a community setting: case series.

Ther Adv Med Oncol. 2025 Jul 8;17:17588359251351121. doi: 10.1177/17588359251351121. eCollection 2025.

Survival analysis of HER2 receptor negative and HER2 receptor low breast cancer patients at a Philippine Tertiary Government Hospital.

Ecancermedicalscience. 2025 Feb 6;19:1840. doi: 10.3332/ecancer.2025.1840. eCollection 2025.

Effectiveness of Kinesio Taping for Lymphedema in the Post-Mastectomy Patient: A Systematic Review of Randomized Controlled Trials.

J Clin Med. 2025 Mar 3;14(5):1700. doi: 10.3390/jcm14051700.

Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis.

Cancer Biol Ther. 2025 Dec;26(1):2445220. doi: 10.1080/15384047.2024.2445220. Epub 2024 Dec 20.

Predictive models for breast cancer-related lymphedema after mastectomy.

Am J Transl Res. 2024 Sep 15;16(9):4623-4632. doi: 10.62347/ZJAZ6071. eCollection 2024.

Construction and validation of a nomogram for predicting the prognosis of breast cancer patients who received adjuvant therapy: an analysis based on the SEER database.

Gland Surg. 2024 Jun 30;13(6):927-941. doi: 10.21037/gs-23-537. Epub 2024 Jun 27.

Diabetes Driven Oncogenesis and Anticancer Potential of Repurposed Antidiabetic Drug: A Systemic Review.

Cell Biochem Biophys. 2024 Sep;82(3):1907-1929. doi: 10.1007/s12013-024-01387-6. Epub 2024 Jul 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验